Citation:Schild SE, Stella PJ, Geyer SM, Bonner JA, Marks RS, McGinnis WL, et al 2002

From Cancer Guidelines Wiki

Citation


Schild SE, Stella PJ, Geyer SM, Bonner JA, Marks RS, McGinnis WL, et al. Phase III trial comparing chemotherapy plus once-daily or twice-daily radiotherapy in Stage III non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2002 Oct 1;54(2):370-8 Available from: http://www.ncbi.nlm.nih.gov/pubmed/12243810.



Critical appraisals

Critical appraisal linkClinical questionAssigned toStatus
What is the optimal radiation dose and fractionation schedule for good performance status patients with inoperable stage III NSCLC undergoing curative therapy?Dr Margot Lehman MBBS FRANZCR GDPcompleted

Compare quality appraisals for each clinical question

  • [[Clinical question:What is the optimal radiation dose and fractionation schedule for good performance status patients with inoperable stage III NSCLC undergoing curative therapy?|
    Invalid title «<span class="smw-format list-format "><span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:What is the optimal radiation dose and fractionation schedule for good performance status patients with inoperable stage III NSCLC undergoing curative therapy?</span></span></span></span>»
    ]] (compare critical appraisals)

Cited by

  1. What is the optimal radiation dose and fractionation schedule for good performance status patients with inoperable stage III NSCLC undergoing curative therapy?